Trade Vir Biotechnology VIR

VirBiotechnology live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Jun 22, 06:19

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages

Vir Biotechnology Inc
Webhose 2026 Jun 21, 08:23

Vir Biotechnology (VIR) Stock Could Be 56% Undervalued After New PSMA Data

Vir Biotechnology Inc
Webhose 2026 Jun 18, 05:29

Is Vir Biotechnology (VIR) Quietly Recasting Its Governance Strength With a New Audit Committee Chair?

Vir Biotechnology Inc
Webhose 2026 Jun 15, 00:00

Clinical Cure for Hepatitis B: Race Enters Decisive Phase, Fastest Candidate May Hit Market in 2027

Vir Biotechnology Inc
Webhose 2026 Jun 11, 14:34

Assessing Vir Biotechnology (VIR) Valuation As Timothy Coughlin Takes Board And Audit Committee Roles

Vir Biotechnology Inc
Webhose 2026 Jun 11, 12:47

Morgan Stanley Raises Vir Biotechnology (NASDAQ:VIR) Price Target to $27.00

Vir Biotechnology Inc
Webhose 2026 Jun 10, 20:05

Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors | Morningstar

Vir Biotechnology Inc
Webhose 2026 Jun 10, 07:50

WINTON GROUP Ltd Buys 131,555 Shares of Vir Biotechnology, Inc. $VIR - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Jun 07, 20:14

Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now?

Vir Biotechnology Inc
Webhose 2026 Jun 07, 15:16

Does Vir Biotechnology (VIR) Board Shuffle Hint At A Deeper Shift Toward Oncology?

Vir Biotechnology Inc
Webhose 2026 Jun 05, 03:55

Vir Biotechnology (NASDAQ:VIR) Director Sells $30,240.00 in Stock - Daily Political

Vir Biotechnology Inc
Webhose 2026 Jun 05, 00:12

Reviewing Beam Therapeutics (NASDAQ:BEAM) & Vir Biotechnology (NASDAQ:VIR) - Stock Observer

Vir Biotechnology Inc
Webhose 2026 Jun 04, 00:20

Analysts Offer Insights on Healthcare Companies: Cabaletta Bio (CABA) and Vir Biotechnology (VIR)

Vir Biotechnology Inc
Webhose 2026 Jun 03, 15:00

VIR Maintained by Leerink Partners -- Price Target Raised to $21

Vir Biotechnology Inc
Webhose 2026 Jun 03, 14:41

Vir Biotechnology (NASDAQ:VIR) Price Target Raised to $21.00

Vir Biotechnology Inc
Webhose 2026 Jun 03, 07:41

Leerink Partners Forecasts Strong Price Appreciation for Vir Biotechnology (NASDAQ:VIR) Stock - Daily Political

Vir Biotechnology Inc
Webhose 2026 Jun 03, 01:09

Insider Sell: Brent Sabatini Sells Shares of Vir Biotechnology Inc (VIR)

Vir Biotechnology Inc
Webhose 2026 Jun 03, 01:09

Insider Sell: Janet Napolitano Sells 3,200 Shares of Vir Biotechnology Inc (VIR)

Vir Biotechnology Inc
Webhose 2026 Jun 02, 00:00

Vir Biotechnology Inc. (VIR) - Insider Monkey

Vir Biotechnology Inc
Webhose 2026 May 28, 08:13

Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Average Rating of "Moderate Buy" from Analysts

Vir Biotechnology Inc
Webhose 2026 May 28, 08:09

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Rating of "Moderate Buy" by Analysts

Vir Biotechnology Inc
Webhose 2026 May 27, 11:07

UBS Group AG Purchases 203,203 Shares of Vir Biotechnology, Inc. $VIR

Vir Biotechnology Inc

VirBiotechnology News

number1 2025 Dec 05, 00:01

Pimco's Triumph in 2025: A Bold Bond Strategy Pays Off

number1 2025 Dec 04, 00:00

Fed Independence on the Line? Political Influence in 2026

number1 2025 Dec 04, 00:00

US Holiday Shopping Season: Record Online Sales Amid Economic Vulnerabilities

number1 2025 Dec 03, 00:00

US Economic Outlook 2026: A Roubini Analysis

number1 2025 Dec 02, 00:01

Fed's Divergent Votes: A Sign of Policy Uncertainty?

Frances Wang 2024 Dec 29, 16:00

Trading wisdom: how can I improve myself as a trader?

Frances Wang 2024 Dec 26, 16:00

Can you trade CFDs on crypto: platform to trade cryptocurrency CFDs

Frances Wang 2024 Dec 25, 16:00

EQV stock price today: Is EQV Ventures a good investment?

Frances Wang 2024 Dec 25, 16:00

How to start investing in dividend ETFs: 7 Dividend ETFs to Watch

Frances Wang 2024 Dec 23, 16:00

TSLQ ETF price forecast: How to track TSLQ ETF prices?

Latest news

Show more
number1 2026 Mar 14, 00:00

Russia Reportedly Providing Intelligence Support to Iran Amidst Escalating Middle East Conflict

number1 2026 Mar 14, 00:00

US Economic Signals: Inflation Concerns and Growth Challenges

number1 2026 Mar 14, 00:00

Gold Market Analysis: Navigating Stability Amidst Escalating Geopolitical Tensions

number1 2026 Mar 14, 00:00

Apple Slashes App Store Commissions in China for Developers

number1 2026 Mar 14, 00:00

Geopolitical Tensions, Economic Crosscurrents, and Technological Advancements: A Forward-Looking Analysis

number1 2026 Mar 13, 12:07

Aussie Dollar Sees Surge in Bullish Bets Ahead of Reserve Bank of Australia Rate Decision

number1 2025 Dec 06, 00:00

India's Silver Demand Surge: New Loan Framework Boosts Market

number1 2025 Dec 04, 00:00

ADP Employment Data and the Fed's Policy Path: A Closer Look

Info

Spread

0.08

Spread (%)

0.7921 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Wednesday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1713504000

Shares Outstanding

168651974

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-3.13

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. It has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Trustpilot